4//SEC Filing
Downs Christopher 4
Accession 0001683168-24-002286
CIK 0001729427other
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 9:51 PM ET
Size
7.9 KB
Accession
0001683168-24-002286
Insider Transaction Report
Form 4
Downs Christopher
Chief Financial Officer
Transactions
- Award
Option to purchase common stock
2024-04-08+40,000→ 201.572 totalExercise: $0.26Exp: 2034-04-08→ Common Stock (40,000 underlying) - Award
Restricted Stock Units
2024-04-08+40,000→ 241.572 total→ Common Stock (40,000 underlying)
Footnotes (4)
- [F1]The options set forth in the table vest in 36 equal monthly installments over three years.
- [F2]Issued in connection with the reporting person's employment with the Company.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Company common stock.
- [F4]The restricted stock units set forth in the table vest in eight equal quarterly installments over two years.
Documents
Issuer
CNS Pharmaceuticals, Inc.
CIK 0001729427
Entity typeother
Related Parties
1- filerCIK 0001705978
Filing Metadata
- Form type
- 4
- Filed
- Apr 9, 8:00 PM ET
- Accepted
- Apr 10, 9:51 PM ET
- Size
- 7.9 KB